Symeres

Kerkenbos 1013
6546 BB Nijmegen
Netherlands

Contact WebSite

Article

Symeres Appoints Gabriella Gentile as Chief Operating Officer
01.10.2025 • News

Symeres Appoints Gabriella Gentile as Chief Operating Officer

Symeres has appointed Gabriella Gentile as Chief Operating Officer to lead global operations and drive transatlantic growth, leveraging her extensive experience in the pharmaceutical and biotech sectors.

Symeres Acquires DGr Pharma
10.09.2025 • News

Symeres Acquires DGr Pharma

CRDMO Symeres has acquired DGr Pharma, expanding its capabilities with DGr Pharma’s regulatory and consultancy expertise to provide more comprehensive drug development services.

Symeres Strengthens US Foothold with Exemplify Buy
27.10.2022 • News

Symeres Strengthens US Foothold with Exemplify Buy

Dutch CDMO Symeres has acquired Exemplify Biopharma, a US-based contract research organization (CRO) based in Cranbury, New Jersey, USA. The deal further strengthens Symeres’ foothold in the US, where it already generates about 50% of its revenues.

Symeres Boosts US Foothold with Organix Buy
05.05.2022 • News

Symeres Boosts US Foothold with Organix Buy

Symeres, a Dutch CDMO and contract research organization, has acquired Organix, a US-based specialized organic chemistry services producer that focuses on lipids. The two firms are highly complementary and the combination unlocks significant strategic value, said Symeres, which generates nearly 50% of its revenues in the US.